Policy

Policy

Comparative Effectiveness

Background

Comparative effectiveness research (CER) helps determine which of several health care interventions work best for a given health care problem. Like personalized medicine, the goal of CER is to support high-quality, evidence-based decisions for optimal patient care.

If personalized medicine and comparative effectiveness research are aligned, they can optimize the quality of patient care and decrease systemic costs. PMC is working to ensure that happens.

2012

Patient-Centered Outcomes Research Institute (PCORI) Methodology Committee Report

• PMC Comments: PCORI Methodology Committee Report (PDF)
  September 13, 2012
  

Patient-Centered Outcomes Research Institute (PCORI) Draft National Research Priorities and Research Agenda

• PMC Comments: PCORI Draft National Priorities for Research and Research Agenda (PDF)
  March 14, 2012

2010

Response to New York Times Editorial

• PMC Response to New York Times Editorial on Comparative Effectiveness Research (PDF) 
  September 20, 2010

The Patient Protection and Affordable Care Act of 2010

• PMC Comments to Senate Majority Leader Harry Reid (PDF)
  December 9, 2009

2009

The Comparative Effectiveness Research Act of 2009

• PMC Comments to Speaker Pelosi and Majority Leader Hoyer (PDF)
  November 3, 2009
  
• Letter from Rep. Kurt Schrader Acknowledging PMC Support (PDF)
  October 30, 2009
  

Report - Comparative Effectiveness Research and Personalized Medicine: From Contradiction to Synergy

• PMC Report - Comparative Effectiveness Research and Personalized Medicine: From Contradiction to Synergy (PDF)
  October 28, 2009
  

The American Recovery and Reinvestment Act of 2009

• PMC Comments to Rep. David Obey (PDF)
  January 16, 2009

2007

Letter to Sen. Max Baucus

• PMC Letter to Sen. Max Baucus (PDF)
  November 16, 2007